NEJM Catalyst, volume 6, issue 4

A Novel 10-Year Value-Based Contract to Improve Type 1 Diabetes Care in the Netherlands

Mary Lynch Witkowski 1, 2, 3
David N. Bernstein 4, 5, 6
Jacob S. Riegler 7, 8
Henk-Jan Aanstoot 9
Maarten Akkerman 10
1
 
Member of the Board, International Consortium for Health Outcomes Measurement, Boston, Massachusetts, USA
2
 
Faculty Lecturer, Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA
4
 
Senior Researcher, Harvard Business School, Boston, Massachusetts, USA
5
 
Orthopedic Surgery Resident Physician, Harvard Combined Orthopaedic Residency Program, Mass General Brigham and Harvard Medical School, Boston, Massachusetts, USA
6
 
Visiting Professor, Semmelweis University, Budapest, Hungary
7
 
Health Care Researcher, Harvard Business School, Boston, Massachusetts, USA
8
 
Internal Medicine Resident, Harvard Medical School Primary Care Program, Cambridge Health Alliance, Cambridge, Massachusetts, USA
9
 
Founder and Clinical Research Director, Diabeter, Rotterdam, The Netherlands
10
 
Chair of the Board of Directors, Diabeter, Rotterdam, The Netherlands
Publication typeJournal Article
Publication date2025-03-19
Journal: NEJM Catalyst
scimago Q1
SJR0.654
CiteScore2.8
Impact factor
ISSN26420007
Found 

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Share
Cite this
GOST | RIS | BibTex
Found error?